These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20934403)

  • 1. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
    Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
    Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
    Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
    PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
    Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
    BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
    Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
    Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
    Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
    Göőz M; Göőz P; Luttrell LM; Raymond JR
    J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.
    Yan F; Liu L; Dempsey PJ; Tsai YH; Raines EW; Wilson CL; Cao H; Cao Z; Liu L; Polk DB
    J Biol Chem; 2013 Oct; 288(42):30742-30751. PubMed ID: 24043629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
    Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.
    Itoh Y; Joh T; Tanida S; Sasaki M; Kataoka H; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Kubota H; Mori Y; Ohara H; Nomura T; Higashiyama S; Itoh M
    Cytokine; 2005 Mar; 29(6):275-82. PubMed ID: 15749028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranuclear translocation signaling of HB-EGF carboxy-terminal fragment and mucosal defense through cell proliferation and migration in digestive tracts.
    Tanida S; Kataoka H; Mizoshita T; Shimura T; Kamiya T; Joh T
    Digestion; 2010; 82(3):145-9. PubMed ID: 20588025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.
    Mifune M; Ohtsu H; Suzuki H; Nakashima H; Brailoiu E; Dun NJ; Frank GD; Inagami T; Higashiyama S; Thomas WG; Eckhart AD; Dempsey PJ; Eguchi S
    J Biol Chem; 2005 Jul; 280(28):26592-9. PubMed ID: 15905175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wound-induced ATP release and EGF receptor activation in epithelial cells.
    Yin J; Xu K; Zhang J; Kumar A; Yu FS
    J Cell Sci; 2007 Mar; 120(Pt 5):815-25. PubMed ID: 17284517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
    Roztocil E; Nicholl SM; Davies MG
    Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
    Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
    J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
    Miyazono K
    J Biochem; 2012 Jan; 151(1):1-3. PubMed ID: 21976708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation.
    McClurg UL; Danjo K; King HO; Scott GB; Robinson PA; Crabtree JE
    Microbes Infect; 2015 Mar; 17(3):205-14. PubMed ID: 25499189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.